SUPT4H1 and Huntington disease: For these reasons, we investigated whether targeted ablation of SUPT4H1 (SUPT4H1-edited) in iPSC-NPCs derived from human HD patients increases the therapeutic possibility of autologous stem cell therapy iPSC-NPCs using a mouse HD model.